Form 4: Tevogen Bio Holdings CFO Receives Stock Grant
Insider Transaction (Form 4)
Kirti Desai, Chief Financial Officer of Tevogen Bio Holdings Inc., received 750,000 shares of common stock on September 14, 2026.
Summary
- Grant/award: acquired 750,000 Common Stock on September 14, 2026; holds 992,983 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Kirti Desai — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-14 | Grant/award | Common Stock | 750,000 | — | — | 992,983 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-14 | Grant/award (750,000 shares) |
Keywords
insider transaction, Form 4, TVGN, Tevogen Inc., neutral, Kirti Desai
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.